FRIDAY, Feb. 7, 2025 (HealthDay News) — Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds. The study involved patients with estrogen receptor positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancers. That’s aContinue Reading

THURSDAY, Feb. 6, 2025 (HealthDay News) — A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report. The “personalized cancer vaccines” (PCVs) used by the nine patients in the trial were targeted to genes specific to their tumors, explainedContinue Reading

WEDNESDAY, Jan. 29, 2025 (HealthDay News) — Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might experience loss of balance and coordination, weakness or sensations of numbness, tingling, “pins and needles,” or burning, researchers said in aContinue Reading